Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
October 2015

The FDA has approved flibanserin (Addyi) to treat low or absent libido in women.

ADHD Mortality
In a study in Denmark, attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of mortality, especially in patients 18 years and older and in female patients.

Antidepressants, NSAIDs, and the Risk of Intracranial Hemorrhage
In a large, retrospective cohort study, patients who took an antidepressant concomitantly with a nonsteroidal anti-inflammatory drug (NSAID) were more likely to suffer an intracranial hemorrhage than those who took an antidepressant alone.

In Brief
Synthetic Cannabinoids Dangerous and Readily Available; Women with Memory Impairment Worsen More Quickly than Men

Stimulants for Geriatric Depression
As an adjunct to antidepressants, methylphenidate (Ritalin and others) may improve symptoms of depression in elderly patients and accelerate response.

Biological Therapies in Psychiatry Newsletter written by Alan J. Gelenberg, MD
For over 30 years,
the source for
up-to-date information on psychotropic medications and other biological treatments for mental disorders


Dr. Alan Gelenberg's Blog
Dr. Gelenberg’s thoughts on psychiatry today… and where it’s headed in the future.
BTP Gift Subscriptions
Order and receive 3 bonus issues added to your own subscription as our thanks.
Activate Free Online Access for Residents
Register now, or if you are completing your residency and received a promotional mailing, enter your code.

Subscribe to BTP
Subscribing to BTP is easy! You can receive the print version with online access, or online only.
CME Credit
Earn 12 Category 1 CME credits for answering questions based on material published in BTP throughout the year.

Dr. Gelenberg invites you to join him in Tucson, AZ the week of February 16, 2015 for the 2015 Update on Psychiatry conference. This 4-day live multi-accredited conference will be held at the JW Marriott Starr Pass. This year's program features outstanding speakers from our University and academic institutions around the country including Dr. Alan Gelenberg. Current clinical practices and research focusing on a variety of psychopharmacology topics will be addressed.

For more information and to register go to

Question please contact Leticia Lovallo at or 520.626.1392

BTP Subscriber Quote
"With time as tight as it is, I really appreciate the sheer volume of material that you review and summarize for us. You provide a tremendous service to busy clinicians like me and those we serve. Thanks again!"

- J. Rutherford, M.D.